Estradiol + Trenbolone

Verify with FDA CVM →

32 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
32
Total Reports
16
Deaths Reported
5000.0%
Death Rate

Active Ingredients

EstradiolTrenbolone

Administration Routes

SubcutaneousUnknownOtherIntra-Articular

Species Affected

Cattle 21
Unknown 10
Human 1

Most Affected Breeds

Unknown 11
Crossbred Bovine/Cattle 10
Cattle (unknown) 7
Mixed (Cattle) 2
Red Angus 1
Aberdeen Angus 1

Most Reported Reactions

Death 11
Injection site swelling 11
Respiratory tract disorder NOS 10
Decreased appetite 10
Weight loss 8
Behavioural disorder NOS 3
Potency, Low 3
Implant, Abnormal 3
NT - chronic (broncho)pneumonia/pleuropneumonia 3
Appearance, Abnormal 3
INEFFECTIVE, WEIGHT INC 2
DEATH-TREATMENT FAILURE 2

Outcome Breakdown

Died
16 (37.2%)
Ongoing
13 (30.2%)
Recovered/Normal
10 (23.3%)
Outcome Unknown
4 (9.3%)

Data Summary

Metric Value
Total adverse event reports 32
Reports involving death 16
Case-fatality rate (reported events) 5000.0%
Distinct species in reports 3
Distinct breeds in reports 6
Distinct reactions reported 20
Active ingredients on file 2

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Estradiol + Trenbolone Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 32 adverse event reports referencing Estradiol + Trenbolone, including 16 reports in which the animal died — a 5000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Estradiol, Trenbolone. Reported administration routes include Subcutaneous, Unknown, Other, Intra-Articular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Estradiol + Trenbolone reports are Cattle (21 reports), Unknown (10 reports), Human (1 reports), with Cattle accounting for the largest share. Within those species, Unknown (11), Crossbred Bovine/Cattle (10), Cattle (unknown) (7) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Estradiol + Trenbolone are Death (11), Injection site swelling (11), Respiratory tract disorder NOS (10), Decreased appetite (10). Of the 43 reports with a coded outcome, Died is the leading category at 37.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Estradiol + Trenbolone.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial